ReWalk Robotics (NASDAQ:RWLK) rockets 113% in after-hours trading after the U.S. Food and Drug Administration clears the company’s ReStore soft exo-suit for sale to rehabilitation centers across the U.S.
The suit is intended for use in the treatment of stroke survivors with mobility challenges.
Launch price is $28,900 with leasing options.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.